← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Oak Crest Institute Of Science
Monrovia, CA
$45,711,510
Total funding
20
Grants
Funding over time
peak $10.1M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$45,381,844 · 17
NSF$329,666 · 2
CDC$0 · 1
By mechanism
R01$21,970,706 · 8
U19$21,208,876 · 7
R33$1,371,798 · 1
R21$830,464 · 2
—$329,666 · 2
Investigators at Oak Crest Institute Of Science
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention$4,434,672
U19 · FY2016 · AI
Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention$3,716,710
U19 · FY2018 · AI
Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention$3,651,503
U19 · FY2017 · AI
Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention$3,333,050
U19 · FY2015 · AI
Systematic Development of Antiretroviral Intravaginal Rings for HIV Prevention$3,274,930
U19 · FY2014 · AI
Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention$1,302,826
R01 · FY2022 · AI
Project 4: PK-PD of a Combination Antiretroviral Intravaginal Ring in Women$1,245,113
U19 · FY2018 · AI
Project 5: IND-enabling Critical Path Project: GMP Manufacture of a Combination I$1,146,349
U19 · FY2016 · AI
Project 3: Anti-HIV/SHIV Efficacy of Combination Antiretroviral Intravaginal Ring$1,126,561
U19 · FY2018 · AI
Project 5: IND-enabling Critical Path Project: GMP Manufacture of a Combination I$1,078,750
U19 · FY2018 · AI
Project 3: Anti-HIV/SHIV Efficacy of Combination Antiretroviral Intravaginal Ring$1,071,457
U19 · FY2017 · AI
Project 4: PK-PD of a Combination Antiretroviral Intravaginal Ring in Women$1,031,835
U19 · FY2017 · AI
A Bioresorbable Subdermal Implant for Sustained Delivery of a Novel Maturation Inhibitor to Prevent HIV Infection$914,204
R01 · FY2020 · AI
A Bioresorbable Subdermal Implant for Sustained Delivery of a Novel Maturation Inhibitor to Prevent HIV Infection$904,172
R01 · FY2022 · AI
A Bioresorbable Subdermal Implant for Sustained Delivery of a Novel Maturation Inhibitor to Prevent HIV Infection$890,560
R01 · FY2023 · AI
A Bioresorbable Subdermal Implant for Sustained Delivery of a Novel Maturation Inhibitor to Prevent HIV Infection$886,859
R01 · FY2024 · AI
A Bioresorbable Subdermal Implant for Sustained Delivery of a Novel Maturation Inhibitor to Prevent HIV Infection$877,357
R01 · FY2021 · AI
Project 1: Pharmacokinetics of Combination Antiretroviral Intravaginal Rings$875,428
U19 · FY2017 · AI
Systemic Sustained Release Delivery of Antiretroviral Agents for HIV Prevention$867,958
R01 · FY2015 · AI
Project 3: Anti-HIV/SHIV Efficacy of Combination Antiretroviral Intravaginal Ring$865,518
U19 · FY2014 · AI